Table of Contents
Clint Mahlman, president and chief operating officer of London Drugs, tells this week’s Video Forum how the drug chain’s unique business model meets a variety of needs for consumers in Western Canada, especially during the COVID-19 outbreak. He also discusses the boom in e-commerce, an area in which London Drugs has more than two decades of experience; the company’s health care strategy; and its commitment to service as a differentiator.
